RECURSION PHARMACEUTICALS, INC.
RXRX나스닥Biological Products, (No Diagnostic Substances)US미국
30일 공시 수
5건
최근 2026.11.03
90일 내부자 순매수
-6억 2,415만원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국정기보고서중요도 보통12시간 전10-Q · Quarterly report
RECURSION PHARMACEUTICALS, INC.RXRX
10-Q · 2026.11.03 06:34 KST
- US미국실적중요도 보통12시간 전8-K · Current report (Items 2.02, 5.02, 7.01, 9.01)
RECURSION PHARMACEUTICALS, INC.RXRX
8-K · 2026.11.03 06:32 KST
- US미국실적중요도 보통2026.10.158-K · Current report (Items 1.01, 2.02, 7.01, 8.01, 9.01)
RECURSION PHARMACEUTICALS, INC.RXRX
8-K · 2026.10.15 21:46 KST
- US미국임원·주요주주 소유중요도 보통2026.10.074 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.10.07
- US미국임원·주요주주 소유중요도 보통2026.10.074 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.10.07
- US미국임원·주요주주 소유중요도 낮음2026.10.024 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.10.02
- US미국임원·주요주주 소유중요도 낮음2026.10.024 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.10.02
- US미국주요사항·수시공시중요도 높음2026.09.218-K · Current report (Items 1.01)
RECURSION PHARMACEUTICALS, INC.RXRX
8-K · 2026.09.21 22:05 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.164 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.09.16
- US미국임원·주요주주 소유중요도 보통2026.09.104 · Statement of changes in beneficial ownership
RECURSION PHARMACEUTICALS, INC.RXRX
Form 4 · 2026.09.10